47
Participants
Start Date
June 6, 2019
Primary Completion Date
June 26, 2020
Study Completion Date
July 15, 2020
Elobixibat
Elobixibat is a small molecule and a potent inhibitor of the ileal bile acid transporter (iBAT).
Placebo oral tablet
Placebo identical in appearance to active drug
Mercy Medical Center, Baltimore
Virginia Commonwealth University, Richmond
Integrity Clinical Research, LLC, Doral
Guardian Angel Research Center, Inc., Tampa
Nature Coast Clinical Research, Inverness
American Research Corporation at the Texas Liver Institute, San Antonio
Peak Gastroenterology Associates, Colorado Springs
Hope Clinical Research, Canoga Park
Inland Empire Clinical Trials, LLC, Rialto
University of Washington, Seattle
Lead Sponsor
Albireo
INDUSTRY